Finally, the cumulative incidence for propensity-matched patients also showed diverging curves for the I-ZES and D-ZES group patients, favoring I-ZES, although it did not reach statistical significance, and might be a function of sample size.
← all excerpts
Comparison of the Major Clinical Outcomes for the Use of Endeavor® and Resolute Integrity® Zotarolimus-Eluting Stents During a Three-Year Follow-up.
1
—
—